Article Information
History
- July 14, 2019.
Article Versions
- You are currently viewing Version 1 of this article (July 14, 2019 - 13:38).
- Version 2 (May 9, 2020 - 04:31).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marcus Keatinge1,2,3,*,
- Matthew E. Gegg4,*,
- Lisa Watson1,2,
- Heather Mortiboys2,
- Hai Bui5,
- Astrid van Rens6,
- Dirk J. Lefeber6,7,
- Ryan B. MacDonald1,
- Anthony H.V. Schapira4 and
- Oliver Bandmann1,2,#
- 1Bateson Centre, Firth Court, University of Sheffield, Western Bank Sheffield S10 2TN, UK
- 2Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385a Glossop Road, Sheffield S10 2HQ, UK
- 3Centre for Discovery Brain Sciences, Chancellor’s Building, Edinburgh EH16 4TJ, UK
- 4Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London NW3 2PF, UK
- 5Eli Lilly and Company, Drop Code 1940,Indianapolis, IN 46285 USA
- 6Department of Laboratory Medicine, Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands
- 7Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands
- ↵#Address corresponding author: Prof Oliver Bandmann MD PhD, Sheffield Institute for Translational Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), 385a Glossop Road, Sheffield S10 2HQ, UK. Tel: x44-114-2222261; email: o.bandmann{at}sheffield.ac.uk.
↵* Both authors contributed equally to the manuscript.